Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response

Go back to Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response
(NASDAQ: MDCX) Delayed: 0.45 -0.01 (2.17%)
Previous Close $0.46    52 Week High
Open $0.46    52 Week Low
Day High $0.46    P/E N/A 
Day Low $0.40    EPS
Volume 2,875,785